Vanderbilt Medical Center

Nashville, Tennessee 37232-8774

8 studies enrolling now · 70 studies all time

What they study most

Acinar Cell Carcinoma, Acute Compartment Syndrome, Adhesive Capsulitis, Adhesive Capsulitis of Unspecified Shoulder, Advanced Cancer, Advanced Solid Tumors, Alzheimer Disease, Alzheimer Disease, Early Onset, Amputation, Antibiotic Side Effect, Aortic Dissection, Aortic Valve Incompetence

Studies at this site

• A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies — Recruiting now
• Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study — Recruiting now
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — Recruiting now
• PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation — Recruiting now
• A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) — Recruiting now
• Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial — Recruiting now
• Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study — NO_LONGER_AVAILABLE
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion — Running, not enrolling
• 3D Specimen Maps for RT Planning — Running, not enrolling
• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD — Running, not enrolling
• A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) — Running, not enrolling
• Cholinergic Deep Brain Stimulation for Alzheimer's Disease — Enrolling by invitation
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension — Completed
• Improving Recovery After Orthopaedic Trauma: Cognitive-Behavioral Based Physical Therapy (CBPT) — Completed
• OCS DCD Heart + CAP Continued Follow-Up — Running, not enrolling
• Study of INCA 0186 in Subjects With Advanced Solid Tumors — Stopped early
• Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System — Completed
• A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) — Completed
• Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma — Completed
• Heart EXPAND Continued Access Protocol — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) — Running, not enrolling
• PREVENTion of Clot in Orthopaedic Trauma — Completed
• Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis — Completed
• Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients — Completed
• Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies — Completed
• A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) — Completed
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis — Completed
• Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy — Completed
• A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions — Completed
• Streamlining Trauma Research Evaluation With Advanced Measurement — Completed
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• Short-term Clinical Deterioration After Acute Pulmonary Embolism — Completed
• Pulmonary Embolism Short-term Clinical Outcomes Registry — Completed
• Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections — Completed
• Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients — Completed
• Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients — Completed
• Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol — Completed
• Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) — Completed
• A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) — Completed
• ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients — Stopped early
• Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children — Completed
• A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma — Completed
• Putative Cognitive Enhancer VU319 — Completed
• A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Aortic Valve Replacement With Trifecta(TM) — Completed